Literature DB >> 24812050

Testing the optimality properties of a dual antibiotic treatment in a two-locus, two-allele model.

Rafael Peña-Miller1, Ayari Fuentes-Hernandez, Carlos Reding, Ivana Gudelj, Robert Beardmore.   

Abstract

Mathematically speaking, it is self-evident that the optimal control of complex, dynamical systems with many interacting components cannot be achieved with 'non-responsive' control strategies that are constant through time. Although there are notable exceptions, this is usually how we design treatments with antimicrobial drugs when we give the same dose and the same antibiotic combination each day. Here, we use a frequency- and density-dependent pharmacogenetics mathematical model based on a standard, two-locus, two-allele representation of how bacteria resist antibiotics to probe the question of whether optimal antibiotic treatments might, in fact, be constant through time. The model describes the ecological and evolutionary dynamics of different sub-populations of the bacterium Escherichia coli that compete for a single limiting resource in a two-drug environment. We use in vitro evolutionary experiments to calibrate and test the model and show that antibiotic environments can support dynamically changing and heterogeneous population structures. We then demonstrate, theoretically and empirically, that the best treatment strategies should adapt through time and constant strategies are not optimal.

Entities:  

Keywords:  antibiotic resistance evolution; multidrug combinations; population genetics

Mesh:

Substances:

Year:  2014        PMID: 24812050      PMCID: PMC4032525          DOI: 10.1098/rsif.2013.1035

Source DB:  PubMed          Journal:  J R Soc Interface        ISSN: 1742-5662            Impact factor:   4.118


  44 in total

Review 1.  Lateral gene transfer and the nature of bacterial innovation.

Authors:  H Ochman; J G Lawrence; E A Groisman
Journal:  Nature       Date:  2000-05-18       Impact factor: 49.962

2.  Trends in antimicrobial drug development: implications for the future.

Authors:  Brad Spellberg; John H Powers; Eric P Brass; Loren G Miller; John E Edwards
Journal:  Clin Infect Dis       Date:  2004-04-14       Impact factor: 9.079

3.  European Committee on Antimicrobial Susceptibility Testing (EUCAST) Technical Notes on antimicrobial susceptibility testing.

Authors:  G Kahlmeter; D F J Brown; F W Goldstein; A P MacGowan; J W Mouton; I Odenholt; A Rodloff; C-J Soussy; M Steinbakk; F Soriano; O Stetsiouk
Journal:  Clin Microbiol Infect       Date:  2006-06       Impact factor: 8.067

4.  Antibiotic use: is appropriateness expensive?

Authors:  V von Gunten; J-P Reymond; K Boubaker; E Gerstel; P Eckert; J-C Lüthi; N Troillet
Journal:  J Hosp Infect       Date:  2008-12-04       Impact factor: 3.926

5.  The bacteria fight back.

Authors:  Gary Taubes
Journal:  Science       Date:  2008-07-18       Impact factor: 47.728

6.  Microbiology. Desperately seeking new antibiotics.

Authors:  David J Payne
Journal:  Science       Date:  2008-09-19       Impact factor: 47.728

7.  Randomised clinical trial: the efficacy of a 10-day sequential therapy vs. a 14-day standard proton pump inhibitor-based triple therapy for Helicobacter pylori in Korea.

Authors:  Y S Kim; S J Kim; J H Yoon; K T Suk; J B Kim; D J Kim; D Y Kim; H J Min; S H Park; W G Shin; K H Kim; H Y Kim; G H Baik
Journal:  Aliment Pharmacol Ther       Date:  2011-09-19       Impact factor: 8.171

8.  Generalized equations for the analysis of inhibitions of Michaelis-Menten and higher-order kinetic systems with two or more mutually exclusive and nonexclusive inhibitors.

Authors:  T C Chou; P Talalay
Journal:  Eur J Biochem       Date:  1981-03-16

9.  The rate of bactericidal action of penicillin in vitro as a function of its concentration, and its paradoxically reduced activity at high concentrations against certain organisms.

Authors:  H EAGLE; A D MUSSELMAN
Journal:  J Exp Med       Date:  1948-07       Impact factor: 14.307

10.  Selecting against antibiotic-resistant pathogens: optimal treatments in the presence of commensal bacteria.

Authors:  Rafael Peña-Miller; David Lähnemann; Hinrich Schulenburg; Martin Ackermann; Robert Beardmore
Journal:  Bull Math Biol       Date:  2011-11-05       Impact factor: 1.758

View more
  5 in total

1.  Diffusion-driven enhancement of the antibiotic resistance selection window.

Authors:  Ayari Fuentes-Hernández; Anastasia Hernández-Koutoucheva; Alán F Muñoz; Raúl Domínguez Palestino; Rafael Peña-Miller
Journal:  J R Soc Interface       Date:  2019-09-11       Impact factor: 4.118

2.  Optimising Antibiotic Usage to Treat Bacterial Infections.

Authors:  Iona K Paterson; Andy Hoyle; Gabriela Ochoa; Craig Baker-Austin; Nick G H Taylor
Journal:  Sci Rep       Date:  2016-11-28       Impact factor: 4.379

3.  Time-programmable drug dosing allows the manipulation, suppression and reversal of antibiotic drug resistance in vitro.

Authors:  Mari Yoshida; Sabrina Galiñanes Reyes; Soichiro Tsuda; Takaaki Horinouchi; Chikara Furusawa; Leroy Cronin
Journal:  Nat Commun       Date:  2017-06-08       Impact factor: 14.919

Review 4.  Antimicrobial resistance (AMR) nanomachines-mechanisms for fluoroquinolone and glycopeptide recognition, efflux and/or deactivation.

Authors:  Mary K Phillips-Jones; Stephen E Harding
Journal:  Biophys Rev       Date:  2018-03-10

5.  Growth rate assays reveal fitness consequences of β-lactamases.

Authors:  Fabian Santiago; Evin Doscher; Jay Kim; Manel Camps; Juan Meza; Suzanne Sindi; Miriam Barlow
Journal:  PLoS One       Date:  2020-01-31       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.